Oral ketamine for sickle cell pain crises
Treatments studied
Part of Blood & lymphatic, Brain & nervous system, Genetic & congenital clinical trials.
This trial tests whether taking ketamine by mouth can help treat “vaso-occlusive” pain episodes that may require hospital admission. If it works, it could offer an easier way to manage severe pain during sickle cell crises.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 12 and 24 years old
- Currently need hospital admission for a vaso-occlusive pain crisis
- Have not had past side effects from IV ketamine for this same type of pain that would prevent using ketamine again
- Be willing to participate in the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a fentanyl-like nose spray (sufentanil) to relieve severe pain from a sickle cell crisis in children and teens. It aims to see if it works better than usual pain treatments.
This study looks at how children with sickle cell disease experience and manage pain crises, known as vaso-occlusive crises. The goal is to better understand these events to improve care for children living with this condition.
This trial tests when to start ketamine for children and teens with sickle cell disease who are in pain. It aims to find the best timing to help reduce pain in the emergency room or infusion clinic.
This trial tests if a liquid form of ketamine works as well as a common opioid (oxycodone) for treating pain in the emergency department. If you have arm, leg, back, or neck pain that isn't controlled by first treatments, you may be able to join.
This trial tests if a low dose of ketamine can help relieve pain for people with sickle cell disease who come to the emergency room with a pain crisis. It aims to find a better way to manage pain during these episodes.
This study tests whether a low-dose of ketamine (a pain medicine) can help children and young adults with sickle cell disease who are in a pain crisis. It aims to provide better pain relief while avoiding some side effects of standard painkillers.
Hear when a new Vaso-occlusive Crisis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.